Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 65214-86-0 | MDL No. : | MFCD16660392 |
Formula : | C18H22ClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | HXROHDYGZFFVMO-UHFFFAOYSA-N |
M.W : | 303.83 | Pubchem ID : | 44153518 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 92.58 |
TPSA : | 21.26 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.18 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 4.19 |
Log Po/w (WLOGP) : | 3.64 |
Log Po/w (MLOGP) : | 3.24 |
Log Po/w (SILICOS-IT) : | 3.86 |
Consensus Log Po/w : | 2.99 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.52 |
Solubility : | 0.00913 mg/ml ; 0.00003 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -4.35 |
Solubility : | 0.0137 mg/ml ; 0.0000451 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.91 |
Solubility : | 0.000371 mg/ml ; 0.00000122 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.62 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 53499-40-4 ]
2-(Benzhydryloxy)-N-methylethanamine hydrochloride
Similarity: 0.82
[ 184845-62-3 ]
4-(o-tolyl)Piperidin-4-ol hydrochloride
Similarity: 0.80
[ 42142-52-9 ]
3-(Methylamino)-1-phenylpropan-1-ol
Similarity: 0.78
[ 53499-40-4 ]
2-(Benzhydryloxy)-N-methylethanamine hydrochloride
Similarity: 0.82
[ 1220034-88-7 ]
4-((4-Iodobenzyl)oxy)piperidine hydrochloride
Similarity: 0.78
[ 58-73-1 ]
2-(Benzhydryloxy)-N,N-dimethylethanamine
Similarity: 0.76
[ 1841081-56-8 ]
3-(4-(Benzyloxy)-2-((dimethylamino)methyl)-1-hydroxycyclohexyl)phenol hydrochloride
Similarity: 0.74
[ 149986-58-3 ]
4-(3-Methoxybenzyl)piperidine hydrochloride
Similarity: 0.72
[ 1220034-88-7 ]
4-((4-Iodobenzyl)oxy)piperidine hydrochloride
Similarity: 0.78
[ 911826-56-7 ]
rel-(2R,4R)-2-Phenyltetrahydro-2H-pyran-4-amine
Similarity: 0.78
[ 149986-58-3 ]
4-(3-Methoxybenzyl)piperidine hydrochloride
Similarity: 0.72
[ 37663-44-8 ]
3H-Spiro[isobenzofuran-1,4'-piperidine] hydrochloride
Similarity: 0.92
[ 173943-98-1 ]
Spiro[isochroman-1,4'-piperidine] hydrochloride
Similarity: 0.90
[ 38309-60-3 ]
3H-Spiro[2-benzofuran-1,4'-piperidine]
Similarity: 0.90
[ 180160-97-8 ]
Spiro[isochroman-1,4'-piperidine]
Similarity: 0.88
[ 184845-62-3 ]
4-(o-tolyl)Piperidin-4-ol hydrochloride
Similarity: 0.80